What is CANC's relative strength rating?

Relative strength percentiles for CANC are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.

What sector is CANC in?

CANC is classified under the Other sector per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.

Is CANC in a leading sector?

Sector RS percentile is not available for Other at this snapshot. Leading sector status (threshold: Other RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.

How volatile is CANC?

Volatility metrics for CANC — average daily range (ADR%), average true range (ATR%), and beta — are not available for the current snapshot. These indicators update daily with each pipeline run.

Does CANC have a seasonal pattern?

TickerStance computes CANC's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what CANC has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did CANC last report earnings?

No SEC EDGAR filings are linked to CANC in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Tema Oncology ETF (CANC) · Neutral

Free

Loading ticker…

§ Seasonality

10y · since 2023

Best monthNov on averageavg +8.43% · 100% win · n 3

Worst monthMar on averageavg -3.10% · 0% win · n 3

CANC monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	CANC Jan avg: 2.58% median: 3.00% win: 67% σ: 3.33% n: 3 2023-08-16 → 2026-07-31	CANC Feb avg: 4.45% median: 5.66% win: 67% σ: 4.17% n: 3 2023-08-16 → 2026-07-31	CANC Mar avg: -3.10% median: -2.88% win: 0% σ: 2.88% n: 3 2023-08-16 → 2026-07-31	CANC Apr avg: 0.13% median: 2.21% win: 67% σ: 4.94% n: 3 2023-08-16 → 2026-07-31	CANC May avg: -0.18% median: 0.68% win: 67% σ: 2.28% n: 3 2023-08-16 → 2026-07-31	CANC Jun avg: 3.65% median: 1.83% win: 100% σ: 4.03% n: 3 2023-08-16 → 2026-07-31	CANC Jul avg: 4.02% median: 4.76% win: 67% σ: 5.25% n: 3 2023-08-16 → 2026-07-31	CANC Aug avg: 1.53% median: 1.70% win: 100% σ: 1.44% n: 3 2023-08-16 → 2026-07-31 (current)	CANC Sep avg: -1.59% median: -4.89% win: 33% σ: 8.17% n: 3 2023-08-16 → 2026-07-31	CANC Oct avg: 0.05% median: -2.78% win: 33% σ: 6.92% n: 3 2023-08-16 → 2026-07-31	CANC Nov avg: 8.43% median: 9.18% win: 100% σ: 7.35% n: 3 2023-08-16 → 2026-07-31	CANC Dec avg: -1.88% median: -2.86% win: 33% σ: 11.27% n: 3 2023-08-16 → 2026-07-31

Filed: May 2026

HOLDINGS

Top holdings of CANC

Top 25 holdings of CANC by portfolio weight
#	Holding	Weight	Value
1	RVMD	7.73%	$14M
2	LLY	4.82%	$8M
3	RHHBY	4.21%	$7M
4	COGT	4.10%	$7M
5	NOVN	4.03%	$7M
6	IMNM	3.91%	$7M
7	CELC	3.58%	$6M
8	MRK	3.57%	$6M
9	NUVL	3.37%	$6M
10	BMY	3.30%	$6M
11	LEGN	2.99%	$5M
12	ABBV	2.81%	$5M
13	EXEL	2.78%	$5M
14	BBIO	2.75%	$5M
15	JNJ	2.55%	$4M
16	CGON	2.43%	$4M
17	GMAB	2.37%	$4M
18	IDYA	2.27%	$4M
19	AMGN	2.11%	$4M
20	ZLAB	1.98%	$3M
21	ONC	1.88%	$3M
22	ZYME	1.51%	$3M
23	ELVN	1.31%	$2M
24	RLAY	1.28%	$2M
25	HALO	1.23%	$2M

Showing 25 of 52 holdings.

CONCENTRATION

Portfolio shape

42.6%Top 10 holdings

52Total holdings

52 (100%)Resolved tickers

SECTORS

Sector breakdown

Healthcare

81.1%

Other

3.4%

Unclassified

8.2%

INTERNALS

What the holdings are doing

Above 50dma (count): 80%
Above 50dma (weight): 80.5%
Above 200dma (count): 77%
Above 200dma (weight): 80.9%

Stage mix (by weight)

Stage 1 · 15% of holdingsStage 2 · 50% of holdingsStage 3 · 23% of holdingsStage 4 · 13% of holdings

Median 1M RS: 72
Median 3M RS: 83
Median 6M RS: 72

Accumulation/distribution mix

A: 41%B: 39%C: 12%D: 8%

Metrics matched 49 tickers across 52 holdings rows (81.1% of fund weight). Metrics as of 2026-08-24; holdings from the 2026-05-31 filing.

WHAT CHANGED

Between filings

Position changes from the 2026-02-28 to the 2026-05-31 N-PORT filing.

New positions

New positions holdings in CANC
Holding	Before → after	Δ weight
ELVNEnliven Therapeutics Inc	— → 1.31%	—
IOVAIovance Biotherapeutics Inc	— → 0.65%	—
INBXInhibrx Biosciences Inc	— → 0.60%	—
TRAXFirst Tracks Biotherapeutics I	— → 0.53%	—
BBOTBridgeBio Oncology Therapeutic	— → 0.48%	—

+3 more

Added

Added holdings in CANC
Holding	Before → after	Δ weight
LEGNLegend Biotech Corp

LEADERS INSIDE THE FUND

Leaders inside CANC

Holdings of CANC currently on TickerStance stock-RS leaderboards.

Holdings of CANC on stock-RS leaderboards
Ticker	Weight	Lens	Rank	Stage
RVMD	7.73%	1Y RS	27	Stage 2
COGT	4.10%	1Y RS	132	—
IMNM	3.91%	1Y RS	166	Stage 2
CGON	2.43%	1Y RS	143	Stage 2
ELVN	1.31%	6M RS	127	Stage 2
RLAY	1.28%	1Y RS	28	Stage 2
HALO	1.23%	3M RS	203	Stage 2
RCUS	1.20%	1Y RS	159	Stage 2
ERAS	1.08%	1Y RS	5	—

THEME EXPOSURE

Theme exposure inside CANC

Human Therapeutics — 37% of weight Obesity & Weight-Loss Therapeutics — 15% of weight

SIMILAR FUNDS BY HOLDINGS

Funds similar to CANC

FAQ

Fund FAQ

What does CANC hold?: CANC holds 52 positions; its three largest are RVMD (7.73%), LLY (4.82%), and RHHBY (4.21%) as of May 2026.
How concentrated is CANC?: The top 10 holdings account for 42.6% of CANC's portfolio. Highly concentrated in top names.
What sectors does CANC cover?: CANC's largest sector exposures are Healthcare (81.1%), Other (3.4%).
How fresh is this data?: Holdings are sourced from SEC N-PORT-P filings, published quarterly with a ~60 day lag. The most recent filing for CANC is dated May 2026.

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

—

LDR

—

StageWeinstein stage analysis

—

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D rating

Evidence · 3 of 3

Market backdrop

Pull-back risk if Macro turns < 60

Trend44.9Are the major indexes going up or down lately?30% weight Breadth50.6Is the rally broad-based or narrow?30% weight Leadership42.4Who's leading?20% weight Macro59.0What does the credit & rates environment say?20% weight

Stance47.8● Neutral

Public attention · CANC

Is the crowd watching?

No attention data for this ticker yet — it joins the daily scan once a baseline builds.

FAQ

Frequently asked questions

What is CANC's relative strength rating?: Relative strength percentiles for CANC are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.
What sector is CANC in?: CANC is classified under the Other sector per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Is CANC in a leading sector?: Sector RS percentile is not available for Other at this snapshot. Leading sector status (threshold: Other RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
How volatile is CANC?: Volatility metrics for CANC — average daily range (ADR%), average true range (ATR%), and beta — are not available for the current snapshot. These indicators update daily with each pipeline run.
Does CANC have a seasonal pattern?: TickerStance computes CANC's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what CANC has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Added holdings in CANC
Holding	Before → after	Δ weight
LEGNLegend Biotech Corp

Trimmed

Trimmed holdings in CANC
Holding	Before → after	Δ weight
BBIOBridgebio Pharma Inc	4.75% → 2.75%	−2.00 pp
NOVNNovartis AG	4.96% → 4.03%	−0.93 pp
SNDXSyndax Pharmaceuticals Inc	1.73% → 0.80%	−0.93 pp
BMYBristol-Myers Squibb Co	4.22% → 3.30%	−0.92 pp
GMABGenmab A/S	3.13% → 2.37%	−0.75 pp

+12 more

Exited

Exited holdings in CANC
Holding	Before → after	Δ weight
ACLXArcellx Inc	3.44% → —	—
NRIXNurix Therapeutics Inc	0.97% → —	—
DAWNDay One Biopharmaceuticals Inc	0.81% → —	—
ARGXArgenx SE	0.80% → —	—
TERNTerns Pharmaceuticals Inc	0.74% → —	—

+3 more

Tema Oncology ETF (CANC) · Neutral | TickerStance

CANC is not confirmed as a leader.

§ Seasonality

Top holdings of CANC

Portfolio shape

Sector breakdown

What the holdings are doing

Between filings

Leaders inside CANC

Theme exposure inside CANC

Funds similar to CANC

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

Market backdrop

Is the crowd watching?

Frequently asked questions

How much does it move?

§ Seasonality

Funds similar to CANC

Theme exposure inside CANC

What the holdings are doing

Leaders inside CANC

Between filings

Tema Oncology ETF (CANC) — Stance & relative strength

CANC is not confirmed as a leader.

Top holdings of CANC

Portfolio shape

Sector breakdown

What the holdings are doing

Between filings

Leaders inside CANC

Theme exposure inside CANC

Funds similar to CANC

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

Market backdrop

Is the crowd watching?

Frequently asked questions

How much does it move?

Funds similar to CANC

Theme exposure inside CANC

What the holdings are doing

Leaders inside CANC

Between filings